[HTML][HTML] A review of AI-based radiomics and computational pathology approaches in triple-negative breast cancer: current applications and perspectives
G Corredor, S Bharadwaj, T Pathak… - Clinical Breast …, 2023 - Elsevier
Breast cancer is one of the most common and deadly cancers worldwide. Approximately,
20% of all breast cancers are characterized as triple negative (TNBC). TNBC typically is
associated with a poorer prognosis relative to other breast cancer subtypes. Due to its
aggressiveness and lack of response to hormonal therapy, conventional cytotoxic
chemotherapy is the usual treatment; however, this treatment is not always effective, and an
important percentage of patients develop recurrence. More recently, immunotherapy has …
20% of all breast cancers are characterized as triple negative (TNBC). TNBC typically is
associated with a poorer prognosis relative to other breast cancer subtypes. Due to its
aggressiveness and lack of response to hormonal therapy, conventional cytotoxic
chemotherapy is the usual treatment; however, this treatment is not always effective, and an
important percentage of patients develop recurrence. More recently, immunotherapy has …
以上显示的是最相近的搜索结果。 查看全部搜索结果